Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 232 clinical trials
Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis

Phase 2b study designed to evaluate the efficacy and safety of ASLAN004 in adult patients with moderate-to-severe Atopic Dermatitis (AD) who are candidates for systemic therapy. This study will

corticosteroids
topical agents
topical corticosteroid
  • 0 views
  • 18 May, 2022
  • 29 locations
A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis

The purpose of this study is to evaluate the effectiveness and safety of 3 dose regimen of CC-93538 in adult participants with moderate to severe Atopic Dermatitis (AD).

asthma
topical agents
ultraviolet light
corticosteroids
montelukast
  • 10 views
  • 06 Jun, 2022
  • 75 locations
A Study Investigating the Effect of EDP1815 in the Treatment of Mild, Moderate and Severe Atopic Dermatitis

The purpose of this research study is to determine whether the study drug, EDP1815, is safe and effective in the treatment of atopic dermatitis compared with placebo. The study will look at

  • 0 views
  • 05 Jun, 2022
  • 56 locations
Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis

This is a parallel, treatment, Phase 2, double-blind, 2-arm, placebo-controlled study with 2 staggered cohorts (2 arms in each cohort) to evaluate the efficacy and safety of rilzabrutinib in adult participants (aged at least 18 years) with moderate-to-severe AD and intolerance or inadequate response to topical corticosteroids (TCS). The total …

topical corticosteroid
corticosteroids
topical agents
eczema
  • 0 views
  • 30 May, 2022
  • 14 locations
Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis

This is an up to 22-week clinical study in adult participants with moderate to severe atopic dermatitis (AD). The purpose of the study is to test a new tablet (LEO 152020) to see if it

topical agents
eczema
  • 0 views
  • 29 May, 2022
  • 36 locations
A Study Evaluating AMG 451 in Moderate To-severe Atopic Dermatitis (ROCKET-IGNITE)

The purpose of this study is to evaluate the efficacy and safety of AMG 451 in monotherapy treatment.

  • 0 views
  • 15 Jun, 2022
  • 2 locations
Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis

This is a parallel, treatment, Phase 2, double-blind, 2-arm, placebo-controlled study with 2 staggered cohorts (2 arms in each cohort) to evaluate the efficacy and safety of rilzabrutinib in adult participants (aged at least 18 years) with moderate-to-severe AD and intolerance or inadequate response to topical corticosteroids (TCS). The total …

topical corticosteroid
corticosteroids
topical agents
eczema
  • 12 views
  • 17 Jun, 2022
  • 17 locations
Non-invasive Photoacoustic Imaging of Skin Inflammatory Disorders With Machine Learning-assisted Scoring

Inflammatory skin disorders are usually assessed by disease scoring system such as Scoring AD (SCORAD)/Eczema Area and Severity Index (EASI) and Psoriasis Area and Severity Index (PASI) for

Accepts healthy volunteers
dermatitis
plaque psoriasis
diabetes
eczema
  • 4 views
  • 19 Apr, 2022
  • 1 location
Infancy to Toddlerhood: Early Nutrition & Tolerance (INTENT)

healthy infants and parents with infants with eczema in introducing complementary feeding in line with new feeding guidelines for diet diversity, gather parental experiences of feeding, support early

  • 0 views
  • 19 Apr, 2021
  • 1 location
Deployment o the Multidisciplinary Prospective Cohort Imminent (IMMINeNT)

Immune-mediated inflammatory diseases (IMIDs) most often affect young patients and have high impact on morbidity and mortality with a significant alteration in the quality of life of patients with professional, social and emotional repercussions. Beyond this burden, IMIDs share many common pathophysiological mechanisms and treatments, known as "targeted therapies". Despite …

disease or disorder
  • 0 views
  • 09 Jun, 2022
  • 1 location